EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSCSEG00000013093
Gene Symbol: ECE1
3 Cross references
231 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSCSEG00000000438
Gene Symbol: EDNRA
3 Cross references
205 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCSEG00000018794
Gene Symbol: EDNRB
1 Cross references
178 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCSEG00000009847
Gene Symbol: EDNRB
1 Cross references
200 Possible Orthologues:

Endothelin Receptor Type B-Like

Ensembl ID : ENSCSEG00000005162
Gene Symbol: LOC103389133
3 Cross references
201 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCSEG00000016120
Gene Symbol: EZH2
3 Cross references
240 Possible Orthologues:

Ephrin Type-B Receptor 4-Like

Ensembl ID : ENSCSEG00000005849
Gene Symbol: LOC103389888
3 Cross references
168 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCSEG00000011544
Gene Symbol: EGFR
3 Cross references
212 Possible Orthologues:

Equilibrative Nucleoside Transporter 1

Ensembl ID : ENSCSEG00000003107
Gene Symbol: LOC103387069
3 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSCSEG00000009269
Gene Symbol: ERBB2
1 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCSEG00000003105
Gene Symbol: ERBB3
3 Cross references
210 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCSEG00000005905
Gene Symbol: ERBB4
3 Cross references
243 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).